Bruker Operating Income 2012-2026 | BRKR
Bruker annual/quarterly operating income history and growth rate from 2012 to 2026. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- Bruker operating income for the quarter ending March 31, 2026 was $0.010B, a 67.92% decline year-over-year.
- Bruker operating income for the twelve months ending March 31, 2026 was $0.047B, a 78.83% decline year-over-year.
- Bruker annual operating income for 2025 was $0.068B, a 73.05% decline from 2024.
- Bruker annual operating income for 2024 was $0.253B, a 42.07% decline from 2023.
- Bruker annual operating income for 2023 was $0.437B, a 0.97% increase from 2022.
|
Bruker Annual Operating Income (Millions of US $) |
|
|---|---|
| 2025 | $68 |
| 2024 | $253 |
| 2023 | $437 |
| 2022 | $433 |
| 2021 | $413 |
| 2020 | $248 |
| 2019 | $301 |
| 2018 | $262 |
| 2017 | $220 |
| 2016 | $182 |
| 2015 | $146 |
| 2014 | $105 |
| 2013 | $148 |
| 2012 | $156 |
| 2011 | $156 |
|
Bruker Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2026-03-31 | $10 |
| 2025-12-31 | $76 |
| 2025-09-30 | $-52 |
| 2025-06-30 | $12 |
| 2025-03-31 | $32 |
| 2024-12-31 | $72 |
| 2024-09-30 | $68 |
| 2024-06-30 | $48 |
| 2024-03-31 | $65 |
| 2023-12-31 | $104 |
| 2023-09-30 | $125 |
| 2023-06-30 | $86 |
| 2023-03-31 | $123 |
| 2022-12-31 | $131 |
| 2022-09-30 | $131 |
| 2022-06-30 | $74 |
| 2022-03-31 | $97 |
| 2021-12-31 | $125 |
| 2021-09-30 | $113 |
| 2021-06-30 | $86 |
| 2021-03-31 | $89 |
| 2020-12-31 | $113 |
| 2020-09-30 | $81 |
| 2020-06-30 | $38 |
| 2020-03-31 | $16 |
| 2019-12-31 | $118 |
| 2019-09-30 | $88 |
| 2019-06-30 | $54 |
| 2019-03-31 | $42 |
| 2018-12-31 | $106 |
| 2018-09-30 | $69 |
| 2018-06-30 | $49 |
| 2018-03-31 | $38 |
| 2017-12-31 | $95 |
| 2017-09-30 | $51 |
| 2017-06-30 | $35 |
| 2017-03-31 | $38 |
| 2016-12-31 | $82 |
| 2016-09-30 | $46 |
| 2016-06-30 | $20 |
| 2016-03-31 | $34 |
| 2015-12-31 | $71 |
| 2015-09-30 | $28 |
| 2015-06-30 | $32 |
| 2015-03-31 | $15 |
| 2014-12-31 | $45 |
| 2014-09-30 | $5 |
| 2014-06-30 | $35 |
| 2014-03-31 | $21 |
| 2013-12-31 | $61 |
| 2013-09-30 | $32 |
| 2013-06-30 | $44 |
| 2013-03-31 | $12 |
| 2012-12-31 | $39 |
| 2012-09-30 | $60 |
| 2012-06-30 | $22 |
| 2012-03-31 | $34 |
| 2011-12-31 | $54 |
| 2011-09-30 | $38 |
| 2011-06-30 | $39 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Computer and Technology | Scientific Instruments Manufacturing | $5.722B | $3.437B |
| Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science reports under two groups: Bruker BioSpin Group & Bruker CALID Group. The Bruker BioSpin comprises the Bruker Magnetic Resonance & Preclinical Imaging divisions, which designs, manufactures & distributes enabling life science tools based on the magnetic resonance technology. The Bruker CALID comprises the Bruker Daltonics & primarily designs, manufactures & distributes life-science mass spectrometry instruments that can be integrated with other sample preparation or chromatography instruments. BSI Nano designs, manufactures & distributes advanced X-ray instruments to determine the characteristics of matter & the three-dimensional structure of molecules. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kewaunee Scientific (KEQU) | United States | $0.100B | 8.24 |
| Harvard Bioscience (HBIO) | United States | $0.019B | 0.00 |